Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;37(5):723-725.
doi: 10.1111/dme.14300. Epub 2020 Apr 3.

COVID-19 and Diabetes

Free PMC article

COVID-19 and Diabetes

R C W Ma et al. Diabet Med. .
Free PMC article

Comment on

Similar articles

See all similar articles

Cited by 2 articles


    1. Baud D, Qi X, Nielsen‐Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID‐19 infection. Lancet Infect Dis 2020; 10.1016/S1473-3099(20)30195-X. Epub 12 March 2020. - DOI
    1. Wu H, Lau ESH, Ma RCW, Kong APS, Wild SH, Goggins W et al Secular trends in all‐cause and cause‐specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study. Diabetologia 2020; 63: 757–766. - PubMed
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 10.1056/NEJMoa2002032. Epub 28 February 2020. - DOI
    1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395 (10024): 565–574. - PMC - PubMed
    1. Hoffman M, Kleine‐Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al SARS‐CoV‐2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020: 10.1016/j.cell.2020.02.0524. Epub 4 March 2020. - DOI

Supplementary concepts